Keywords: isogenica, signs, peptide, deal, wyeth, cambridge, uk-based

Isogenica signs peptide deal with Wyeth

Article | 11 June 2007

Print This

Cambridge, UK-based Isogenica has entered into a research and licensing agreement with US drug major Wyeth. Under the terms of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in